Company Comparison
ContralinePioneering male birth control vs 23andMe
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | ContralinePioneering male birth control | 23andMe |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Charlottesville, VA | South San Francisco, California |
| Founded | 2015 | 2006 |
| Status | Active | Active |
| Last Funding Stage | Series A | — |
| Total Funding | $23M | — |
| Valuation | — | — |
What They Build
ContralinePioneering male birth control
Biotechnology company developing innovative male contraceptive solutions including non-hormonal birth control methods.
23andMe
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California.
Key Investors
ContralinePioneering male birth control
Sector Overlap
Both ContralinePioneering male birth control and 23andMe operate in Biotech.
Browse all Biotech companies →